Moon C, Belabed M, Park M, Mattiuz R, Puleston D, Merad M
Nat Rev Cancer. 2025; .
PMID: 39920276
DOI: 10.1038/s41568-024-00787-3.
Luri-Rey C, Teijeira A, Wculek S, de Andrea C, Herrero C, Lopez-Janeiro A
Nat Rev Cancer. 2025; .
PMID: 39881005
DOI: 10.1038/s41568-024-00785-5.
Degavre C, Lepez A, Ibanez S, Francois C, Glowacka K, Guilbaud C
J Immunother Cancer. 2024; 12(11).
PMID: 39500528
PMC: 11552574.
DOI: 10.1136/jitc-2024-009752.
Bosteels V, Janssens S
Nat Rev Immunol. 2024; 25(2):125-140.
PMID: 39289483
DOI: 10.1038/s41577-024-01079-5.
Gerlini G, Susini P, Sestini S, Brandani P, Giannotti V, Borgognoni L
Cancers (Basel). 2024; 16(10).
PMID: 38791968
PMC: 11119378.
DOI: 10.3390/cancers16101890.
Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma.
Trojan A, Lone Y, Briceno I, Trojan J
Curr Med Chem. 2023; 31(15):1983-2002.
PMID: 38031775
DOI: 10.2174/0109298673237968231106095141.
Determinants for Antitumor and Protumor Effects of Programmed Cell Death.
Workenhe S, Inkol J, Westerveld M, Verburg S, Worfolk S, Walsh S
Cancer Immunol Res. 2023; 12(1):7-16.
PMID: 37902605
PMC: 10762341.
DOI: 10.1158/2326-6066.CIR-23-0321.
Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors.
Wijfjes Z, van Dalen F, Le Gall C, Verdoes M
Mol Pharm. 2023; 20(10):4826-4847.
PMID: 37721387
PMC: 10548474.
DOI: 10.1021/acs.molpharmaceut.3c00330.
The emerging role of noncoding RNAs in systemic lupus erythematosus: new insights into the master regulators of disease pathogenesis.
Nour M, Ghorbaninezhad F, Asadzadeh Z, Baghbanzadeh A, Hassanian H, Leone P
Ther Adv Chronic Dis. 2023; 14:20406223231153572.
PMID: 37035097
PMC: 10074641.
DOI: 10.1177/20406223231153572.
Immunogenic cell death triggered by impaired deubiquitination in multiple myeloma relies on dysregulated type I interferon signaling.
Waad Sadiq Z, Brioli A, Al-Abdulla R, Cetin G, Schutt J, Murua Escobar H
Front Immunol. 2023; 14:982720.
PMID: 36936919
PMC: 10018035.
DOI: 10.3389/fimmu.2023.982720.
Regulation of immunological tolerance by the p53-inhibitor iASPP.
Akama-Garren E, Miller P, Carroll T, Tellier M, Sutendra G, Buti L
Cell Death Dis. 2023; 14(2):84.
PMID: 36746936
PMC: 9902554.
DOI: 10.1038/s41419-023-05567-9.
The role of dendritic cells in the immunomodulation to implanted biomaterials.
Wang S, Chen Y, Ling Z, Li J, Hu J, He F
Int J Oral Sci. 2022; 14(1):52.
PMID: 36333287
PMC: 9636170.
DOI: 10.1038/s41368-022-00203-2.
Treatment of in vitro generated Langerhans cells with JAK-STAT inhibitor reduces their inflammatory potential.
Ann S, Ibo J, Megha M, Reu Hans D, Bruggen Laura V, Julien L
Clin Exp Med. 2022; 23(6):2571-2582.
PMID: 36282458
DOI: 10.1007/s10238-022-00899-w.
Emerging roles of neutrophils in immune homeostasis.
Lee M, Lee S, Bae Y
BMB Rep. 2022; 55(10):473-480.
PMID: 36104260
PMC: 9623243.
Antigen targeting to dendritic cells: Still a place in future immunotherapy?.
Stoitzner P, Romani N, Rademacher C, Probst H, Mahnke K
Eur J Immunol. 2022; 52(12):1909-1924.
PMID: 35598160
PMC: 10084009.
DOI: 10.1002/eji.202149515.
Harnessing Tolerogenic Histone Peptide Epitopes From Nucleosomes for Selective Down-Regulation of Pathogenic Autoimmune Response in Lupus (Past, Present, and Future).
Datta S
Front Immunol. 2021; 12:629807.
PMID: 33936042
PMC: 8080879.
DOI: 10.3389/fimmu.2021.629807.
Immune Milieu Established by Postpartum Liver Involution Promotes Breast Cancer Liver Metastasis.
Bartlett A, Pennock N, Klug A, Schedin P
Cancers (Basel). 2021; 13(7).
PMID: 33916683
PMC: 8038410.
DOI: 10.3390/cancers13071698.
Hepatic Dendritic Cells in the Development and Progression of Metabolic Steatohepatitis.
Mendez-Sanchez N, Cordova-Gallardo J, Barranco-Fragoso B, Eslam M
Front Immunol. 2021; 12:641240.
PMID: 33833761
PMC: 8021782.
DOI: 10.3389/fimmu.2021.641240.
Soluble N-Acetylgalactosamine-Modified Antigens Enhance Hepatocyte-Dependent Antigen Cross-Presentation and Result in Antigen-Specific CD8 T Cell Tolerance Development.
Damo M, Wilson D, Watkins E, Hubbell J
Front Immunol. 2021; 12:555095.
PMID: 33746941
PMC: 7965950.
DOI: 10.3389/fimmu.2021.555095.
Tethering Innate Surface Receptors on Dendritic Cells: A New Avenue for Immune Tolerance Induction?.
Lamendour L, Deluce-Kakwata-Nkor N, Mouline C, Gouilleux-Gruart V, Velge-Roussel F
Int J Mol Sci. 2020; 21(15).
PMID: 32722168
PMC: 7432195.
DOI: 10.3390/ijms21155259.